Stock CGTX COGNITION THERAPEUTICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Sector Chart Cognition Therapeutics, Inc.

Equities

CGTX

US19243B1026

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-05-28 pm EDT 		5-day change 1st Jan Change
2.2 USD -13.73% Intraday chart for Cognition Therapeutics, Inc. -3.08% +18.92%
May. 07 Cognition Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
Apr. 29 Cognition Therapeutics, Inc. Completes Enrollment in Phase 2 SHIMmer Study of CT1812 in Mild-to-Moderate Dementia with Lewy Bodies CI
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

Sector Bio Therapeutic Drugs

Capi. Sales growth Profitability Finances EV / Sales P/E ratio
COGNITION THERAPEUTICS, INC. Stock Cognition Therapeutics, Inc.
 102M - - - - -
VERTEX PHARMACEUTICALS INCORPORATED Stock Vertex Pharmaceuticals Incorporated
 118B
REGENERON PHARMACEUTICALS, INC. Stock Regeneron Pharmaceuticals, Inc.
 106B
BIONTECH SE Stock BioNTech SE
 23.4B -
ARGENX SE Stock argenx SE
 22.1B -
GENMAB A/S Stock Genmab A/S
 18.34B
  1. Stock Market
  2. Equities
  3. CGTX Stock
  4. Charts Cognition Therapeutics, Inc.
  5. Sector Chart